(Press-News.org) San Antonio, Tex. -- A drug that shows promise for preventing breast cancer in postmenopausal women with an increased risk of developing the disease, appears to reduce mammographic breast density in the same group of women. Having dense breast tissue on mammogram is believed to be one of the strongest predictors of breast cancer. The preliminary analysis from the small, phase II study was presented today at the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium in Texas.
The ongoing study at Georgetown Lombardi Comprehensive Cancer Center and the Center for Cancer Research at the National Cancer Institute examines the effect of exemestane (Aromasin®) on breast density. Exemestane is in a class of medications called aromatase inhibitors (AI). It works by decreasing the amount of estrogen produced by the body. This can slow or stop the growth of some breast tumors that need estrogen to grow.
In this study, a preliminary analysis was conducted for the first 23 participants enrolled (42 women were enrolled as of June 2010). Mammograms were taken before the women began exemestane and one year after treatment started. Breast density was compared between the two mammograms for each woman.
"Overall, we saw a seven percent decrease in mammographic density among the women, a statistically significant finding," says Jennifer Eng-Wong, M.D., M.P.H., assistant professor of oncology at Lombardi Comprehensive Cancer Center, a part of Georgetown University Medical Center. "Previous studies with AIs in high risk women have not shown a significant decline in mammographic density and differences in results may be due to duration of treatment or baseline characteristics of the study population."
She says earlier studies with tamoxifen, an FDA-approved drug to reduce breast cancer risk in women at high risk, also reduced breast density. A change in breast density appears to be an intermediate marker for breast cancer. For example a 10 percent drop in breast density was correlated with a 50 percent drop in breast cancer incidence. Tamoxifen is in a different class of drugs. Side-effects of taking it have deterred women from choosing tamoxifen, resulting in a need for other treatment options such as aromatase inhibitors. In general, both of these agents are well tolerated, however rare serious side effects of tamoxifen include thrombo-embolic disease and endometrial cancer. The AIs are not associated with these side effects but have been associated with an increased risk of bone fracture and loss of bone density.
Women who were eligible for the study had an increased risk of breast cancer defined as one of the following: five year Gail model of risk ≥1.7 percent, a high risk breast lesion (e.g. lobular neoplasia or ductal carcinoma in situ), a known BRCA1/2 mutation, or a prior stage I/II breast cancer with treatment completed two years prior to enrolling in the study. Women were excluded if testing revealed osteoporosis.
Eng-Wong points out that this stage of the analysis does not include a control group (women not taking exemestane) with whom the current findings could be compared, but she says a matched control comparison is planned. The study will continue until an analysis can be conducted on mammographic density after two years of treatment.
INFORMATION:
In addition to Eng-Wong authors include Claudine Isaacs, Robert Warren, Philip Cohen and Celia Byrne at Georgetown Lombardi; and David Venzon, Suparna Wedam, Jo Anne Zujewski and Larissa Korde at the NCI.
This research is funded by the NCI Intramural Research Program and Georgetown Lombardi. Pfizer supplied the exemestane used in the study. Eng-Wong reports having no personal financial interests related to the study.
About Georgetown Lombardi Comprehensive Cancer Center
Georgetown Lombardi Comprehensive Cancer Center, part of Georgetown University Medical Center and Georgetown University Hospital, seeks to improve the diagnosis, treatment, and prevention of cancer through innovative basic and clinical research, patient care, community education and outreach, and the training of cancer specialists of the future. Lombardi is one of only 40 comprehensive cancer centers in the nation, as designated by the National Cancer Institute, and the only one in the Washington, DC, area. For more information, go to http://lombardi.georgetown.edu.
About Georgetown University Medical Center
Georgetown University Medical Center is an internationally recognized academic medical center with a three-part mission of research, teaching and patient care (through MedStar Health). GUMC's mission is carried out with a strong emphasis on public service and a dedication to the Catholic, Jesuit principle of cura personalis -- or "care of the whole person." The Medical Center includes the School of Medicine and the School of Nursing and Health Studies, both nationally ranked, the world-renowned Georgetown Lombardi Comprehensive Cancer Center and the Biomedical Graduate Research Organization (BGRO). In fiscal year 2009-2010, GUMC accounted for 79 percent of Georgetown University's extramural research funding.
RICHLAND, Wash. -- New high resolution images of electrode wires made from materials used in rechargeable lithium ion batteries shows them contorting as they become charged with electricity. The thin, nano-sized wires writhe and fatten as lithium ions flow in during charging, according to a paper in this week's issue of the journal Science. The work suggests how rechargeable batteries eventually give out and might offer insights for building better batteries.
Battery developers know that recharging and using lithium batteries over and over damages the electrode materials, ...
Spearheaded by the University of Manchester's Jodrell Bank Observatory and funded by the Science and Technology Facilities Council, the e-MERLIN telescope will allow astronomers to address key questions relating to the origin and evolution of galaxies, stars and planets.
To demonstrate its capabilities, University of Manchester astronomers turned the new telescope array toward the "Double Quasar". This enigmatic object, first discovered by Jodrell Bank, is a famous example of Einstein's theory of gravity in action.
The new image shows how the light from a quasar billions ...
BOSTON, Mass. (December 9, 2010)—A team of researchers from Harvard Medical School, Brigham and Women's Hospital, and Massachusetts General Hospital, with others from the United States and Haiti, has determined that the strain of cholera erupting in Haiti matches bacterial samples from South Asia and not those from Latin America. The scientists conclude that the cholera bacterial strain introduced into Haiti probably came from an infected human, contaminated food or other item from outside of Latin America. It is highly unlikely, they say, that the outbreak was triggered ...
The technique, which they describe in the journal Science, involves rearranging the holes left by missing atoms to tune the properties of dopants – the chemical impurities that give the semiconductors in computer chips their special properties.
Though the technique is currently limited to the laboratory, it could prove valuable to industry in the future, as the continued miniaturization of cell phone and computer chips makes the performance of individual atoms in a semiconductor more important.
"The effect we discovered is probably already going on inside the devices ...
VIDEO:
Neurologists finally have an answer to one of the most important questions about Alzheimer's disease: In a study published in Science Express, researchers show that rising brain levels of a...
Click here for more information.
Neurologists finally have an answer to one of the most important questions about Alzheimer's disease: Do rising brain levels of a plaque-forming substance mean patients are making more of it or that they can no longer clear it from their brains ...
In Alzheimer's disease, a protein fragment called beta-amyloid accumulates at abnormally high levels in the brain. Now researchers funded by the National Institutes of Health have found that in the most common, late-onset form of Alzheimer's disease, beta-amyloid is produced in the brain at a normal rate but is not cleared, or removed from the brain, efficiently. In addition to improving the understanding of what pathways are most important in development of Alzheimer's pathology, these findings may one day lead to improved biomarker measures for early diagnosis as well ...
Silencing the TLR4 gene can stop the process which may lead to cardiovascular disease in diabetic patients. Researchers writing in BioMed Central's open access Journal of Translational Medicine carried out a series of in vitro tests which demonstrated that TLR4 plays a critical role in hyperglycaemic cardiac apoptosis, and that silencing the gene using specific small interfering RNA (siRNA) can prevent it.
Wei-Ping Min, from the University of Western Ontario, Canada, worked with a team of researchers to perform the tests in cells taken from diabetic mice. He said, "We ...
Research, led by the University of Warwick, The Sainsbury Laboratory, and Virginia Polytechnic Institute and State University (Virginia Tech), has sequenced the genome of a plant disease causing organism revealing that it acts like a "stealth bomber of plant pathogens". The research has uncovered the tactics used to sneak past the plant's immune defences. That same discovery also provides tools for researchers to identify the components of the plant immune system and devise new ways to prevent disease.
The research at the University of Warwick, the Sainsbury Laboratory ...
Cancer researchers have identified six gene markers present in early stage non-small cell lung cancer (NSCLC) that show promise in helping oncologists better identify which tumors will relapse after curative surgery, according to a study presented at the 2010 Chicago Multidisciplinary Symposium in Thoracic Oncology. This symposium is sponsored by the American Society for Radiation Oncology (ASTRO), the American Society of Clinical Oncology (ASCO), the International Association for the Study of Lung Cancer (ISLAC) and the University of Chicago.
Lung cancer is the leading ...
ANN ARBOR, Mich. — The cocktail of hormones cascading through depressed mothers' bodies may play an important role in the development of their unborn children's brains.
A higher level of depression in mothers during pregnancy was associated with higher levels of stress hormones in their children at birth, as well as with other neurological and behavioral differences, a University of Michigan-led study found.
"The two possibilities are that they are either more sensitive to stress and respond more vigorously to it, or that they are less able to shut down their stress ...
